×
About 2,508 results

ALLMedicine™ Migraine Headache Center

Research & Reviews  632 results

Ginger for Migraine.
https://doi.org/10.4088/JCP.21f14325
The Journal of Clinical Psychiatry; Andrade C

Dec 2nd, 2021 - Many preclinical and clinical studies have examined the potential benefits of ginger extracts for a range of medical disorders. Ginger has been found to reduce both pain and nausea and has therefore also been studied in the context of migraine hea...

Clinical Effectiveness of Peripheral Nerve Blocks for Diagnosis of Migraine Trigger Poi...
https://doi.org/10.1097/PRS.0000000000008580
Plastic and Reconstructive Surgery; Rangwani SM, Hehr JC et. al.

Dec 1st, 2021 - With a 13 percent global prevalence, migraine headaches are the most commonly diagnosed neurologic disorder, and are a top five cause of visits to the emergency room. Surgical techniques, such as decompression and/or ablation of neurovasculature, ...

Intranasal Ketorolac versus Intravenous Ketorolac for Treatment of Migraine Headaches i...
https://doi.org/10.1111/acem.14422
Academic Emergency Medicine : Official Journal of the Soc... Tsze DS, Lubell TR et. al.

Nov 26th, 2021 - Intravenous ketorolac is commonly used for treating migraine headaches in children. However, the prerequisite placement of an intravenous line can be technically challenging, time-consuming, and associated with pain and distress. Intranasal ketoro...

Parenchymal neuroinflammatory signaling and dural neurogenic inflammation in migraine.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600694
The Journal of Headache and Pain; Erdener ŞE, Kaya Z et. al.

Nov 20th, 2021 - Pain is generally concomitant with an inflammatory reaction at the site where the nociceptive fibers are activated. Rodent studies suggest that a sterile meningeal inflammatory signaling cascade may play a role in migraine headache as well. Experi...

The prevalence and characteristics of visceral autonomic symptoms among migraineurs: A ...
https://doi.org/10.1177/03331024211056849
Cephalalgia : an International Journal of Headache; Togha M, Martami F et. al.

Nov 18th, 2021 - There is limited evidence about visceral autonomic symptoms in the different phases of migraine attack. We evaluated the prevalence of these symptoms in migraineurs before, during, and after headache attacks. In addition, the association between m...

see more →

Guidelines  1 results

Evidence-based guideline update: NSAIDs and other complementary treatments for episodic...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335449
Neurology Holland S, Silberstein SD et. al.

Apr 25th, 2012 - To provide updated evidence-based recommendations for the preventive treatment of migraine headache. The clinical question addressed was: Are nonsteroidal anti-inflammatory drugs (NSAIDs) or other complementary treatments effective for migraine pr...

see more →

Drugs  184 results see all →

Clinicaltrials.gov  54 results

SPG Block for Acute Pediatric Migraine
https://clinicaltrials.gov/ct2/show/NCT03984045

Nov 17th, 2021 - This is a randomized double blind trial comparing an intranasal sphenopalatine block with 2% lidocaine to intravenous (0.15 mg/kg, max 10mg) prochlorperazine in patients greater than 10 years of age presenting to a pediatric emergency department w...

Comparison of Craniosacral Therapy and Myofacial Relaxation Techniques in People Diagnosed With Migraine
https://clinicaltrials.gov/ct2/show/NCT04976725

Nov 9th, 2021 - Headache is a neurological condition that is very common all over the world and is observed at some time in life in more than 90% of society. Migraine headache, known for thousands of years, is one of the oldest diseases of humanity. The word 'hem...

Rate , Predictors and Outcome of Chronic Migraine
https://clinicaltrials.gov/ct2/show/NCT05079659

Oct 15th, 2021 - Nowadays, headache has been considered as one of the top global disabling medical conditions.1 Migraine is an important type of headache, and one of the chronic multifaceted neuro-inflammatory disorders.2 It is characterized by recurrent throbbing...

GORE® CARDIOFORM Septal Occluder Migraine Clinical Study
https://clinicaltrials.gov/ct2/show/NCT04100135

Aug 3rd, 2021 - Multi-center, prospective, randomized, placebo- and sham-controlled study to evaluate the GORE® CARDIOFORM Septal Occluder for migraine headache relief

Study of Sumatriptan Naproxen Sodium Succinate Tablets for the Treatment of Acute Migraine Attacks
https://clinicaltrials.gov/ct2/show/NCT04948164

Jul 7th, 2021 - Migraine is a common chronic nerve vascular disease, the disease characteristic to break out repeatedly, one side or both sides of the pulsatile partial side head, severe headache and can combine autonomic nervous system dysfunction such as nausea...

see more →

News  129 results

Botulinum toxin for chronic pain: What's on the horizon?
https://www.mdedge.com/familymedicine/article/248633/musculoskeletal-disorders/botulinum-toxin-chronic-pain-whats-horizon
MDedge Family Medicine; Caleb Dickison, DO, CAQSM, Jeffrey C. Leggit, MD, CAQSM

Nov 12th, 2021 - Botulinum toxin (BoNT) was first approved by the US Food and Drug Administration (FDA) for the treatment of strabismus and blepharospasm in 1989. Since then, approved indications have expanded to include spasticity, cervical dystonia, severe axill.

No Benefit of Fremanezumab in Posttraumatic Headache
https://www.medscape.com/viewarticle/952761

Jun 9th, 2021 - A phase 2 study of the anti-calcitonin gene–related peptide (CGRP) antibody fremanezumab found no benefit of treatment in persistent posttraumatic headache. Anti-CGRP therapy had been predicted to be effective, given its history of improving other...

Post-Traumatic Migraine Tied to Longer Recovery After Youth Concussion
https://www.medscape.com/viewarticle/947065

Mar 11th, 2021 - (Reuters Health) - Youth who sustain mild traumatic brain injuries may have a longer recovery when they experience migraines than with other types of post-traumatic headache, a new study suggests. Researchers examined data on 281 youth ranging in ...

CGRP May Offer Both Migraine Treatment and Prevention
https://www.medscape.com/viewarticle/943042

Dec 22nd, 2020 - Rimegepant (Nurtec ODT), the first calcitonin gene–related peptide (CGRP) receptor antagonist approved in the United States for the acute treatment of migraine, may help prevent migraine headaches as well. In a phase 2/3 study, oral rimegepant was...

Migraine Nerve Stimulation Device Now Available Over-the-Counter
https://www.medscape.com/viewarticle/939037

Oct 13th, 2020 - The first dual-purpose, external trigeminal nerve stimulation device to treat and prevent acute migraine is now available over-the-counter to adults over age 18. The US Food and Drug Administration (FDA) has cleared Cefaly Dual (Cefaly Technology)...

see more →

Patient Education  3 results see all →